Cargando…

Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen

BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young-Ran, Lee, Young-Hee, Im, Sun-A, Kim, Kyungjae, Lee, Chong-Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153668/
https://www.ncbi.nlm.nih.gov/pubmed/21860609
http://dx.doi.org/10.4110/in.2011.11.3.163
_version_ 1782209916868493312
author Lee, Young-Ran
Lee, Young-Hee
Im, Sun-A
Kim, Kyungjae
Lee, Chong-Kil
author_facet Lee, Young-Ran
Lee, Young-Hee
Im, Sun-A
Kim, Kyungjae
Lee, Chong-Kil
author_sort Lee, Young-Ran
collection PubMed
description BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS: NPs containing a similar amount of ovalbumin (OVA) but different sizes were produced using a micromixer-based W/O/W solvent evaporation procedure, and the efficiency of the NPs to induce the cross-presentation of OVA peptides were examined in dendritic cells (DCs). Cellular uptake and biodistribution studies were performed using fluorescein isothiocyanate (FITC)-loaded NPs in mice. RESULTS: The NPs in the range of 1.1~1.4µm in size were the most and almost equally efficient in inducing the cross-presentation of OVA peptides via H-2K(b) molecules. Cellular uptake and biodistribution studies showed that opsonization of the NPs with mouse IgG greatly increased the percentage of FITC-positive cells in the spleen and lymph nodes. The major cell type of FITC-positive cells in the spleen was macrophages, whereas that of lymph nodes was DCs. CONCLUSION: These results show that IgG-opsonized PLGA-NPs with a mean size of 1.1µm would be the choice of biodegradable carriers for the targeted-delivery of protein antigens for cross-priming in vivo.
format Online
Article
Text
id pubmed-3153668
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Association of Immunologists
record_format MEDLINE/PubMed
spelling pubmed-31536682011-08-22 Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen Lee, Young-Ran Lee, Young-Hee Im, Sun-A Kim, Kyungjae Lee, Chong-Kil Immune Netw Original Article BACKGROUND: Nanoparticles (NPs) prepared from biodegradable polymers, such as poly (D,L-lactic acid-co-glycolic acid) (PLGA), have been studied as vehicles for the delivery of antigens to phagocytes. This paper describes the preparation of antigen-loaded PLGA-NPs for efficient cross-priming. METHODS: NPs containing a similar amount of ovalbumin (OVA) but different sizes were produced using a micromixer-based W/O/W solvent evaporation procedure, and the efficiency of the NPs to induce the cross-presentation of OVA peptides were examined in dendritic cells (DCs). Cellular uptake and biodistribution studies were performed using fluorescein isothiocyanate (FITC)-loaded NPs in mice. RESULTS: The NPs in the range of 1.1~1.4µm in size were the most and almost equally efficient in inducing the cross-presentation of OVA peptides via H-2K(b) molecules. Cellular uptake and biodistribution studies showed that opsonization of the NPs with mouse IgG greatly increased the percentage of FITC-positive cells in the spleen and lymph nodes. The major cell type of FITC-positive cells in the spleen was macrophages, whereas that of lymph nodes was DCs. CONCLUSION: These results show that IgG-opsonized PLGA-NPs with a mean size of 1.1µm would be the choice of biodegradable carriers for the targeted-delivery of protein antigens for cross-priming in vivo. The Korean Association of Immunologists 2011-06 2011-06-30 /pmc/articles/PMC3153668/ /pubmed/21860609 http://dx.doi.org/10.4110/in.2011.11.3.163 Text en Copyright © 2011 The Korean Association of Immunologists http://creativecommons.org/licenses/by-nc/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Young-Ran
Lee, Young-Hee
Im, Sun-A
Kim, Kyungjae
Lee, Chong-Kil
Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title_full Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title_fullStr Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title_full_unstemmed Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title_short Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
title_sort formulation and characterization of antigen-loaded plga nanoparticles for efficient cross-priming of the antigen
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153668/
https://www.ncbi.nlm.nih.gov/pubmed/21860609
http://dx.doi.org/10.4110/in.2011.11.3.163
work_keys_str_mv AT leeyoungran formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen
AT leeyounghee formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen
AT imsuna formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen
AT kimkyungjae formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen
AT leechongkil formulationandcharacterizationofantigenloadedplgananoparticlesforefficientcrossprimingoftheantigen